文献速递心力衰竭与心肌病

长期左心室辅助装置对晚期心衰炎症与心脏重构的影响

Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure
RSS 订阅 · Open Heart

本单中心前瞻性观察研究纳入16例植入HeartMate 3左心室辅助装置的晚期心衰患者,比较植入时与术后12个月的血液指标。结果显示长期左心室辅助装置支持与脑钠肽、C反应蛋白及多种炎症、纤维化和代谢相关循环标志物下降相关。在7例接受心脏移植的亚组中,心肌组织学提示巨噬细胞浸润减少。

要点

  • 长期LVAD支持可降低BNP、CRP及多种炎症和纤维化循环标志物。
  • 心肌组织学显示LVAD支持后巨噬细胞浸润减少。
  • LVAD支持伴随代谢标志物变化,如GDF-15和抵抗素下降、瘦素升高。

核心结论

  • 长期左心室辅助装置支持与生化及血液学指标改善相关,并伴随炎症、代谢和心脏重构循环标志物的协调性变化。

研究设计与样本

  • 单中心前瞻性观察研究,纳入16例连续入组的晚期心衰并符合HeartMate 3左心室辅助装置植入指征的患者。
  • 在装置植入术中及术后12个月分别采集血样进行分析。
  • 在7例后续接受心脏移植的患者亚组中,对植入时和移植后取出的心肌样本进行组织学检查。

主要发现

  • LVAD植入后脑钠肽从324.7±47.0 pg/mL降至124.6±50.3 pg/mL。
  • LVAD植入后C反应蛋白从15.2±3.8 mg/L降至6.0±1.3 mg/L。
  • 循环中纤维化和重构相关介质下降,包括细胞外基质金属蛋白酶诱导因子、成纤维细胞生长因子-2、成纤维细胞生长因子-19、晚期糖基化终末产物受体、可溶性ST2和白细胞介素27。
  • 血管生成相关因子下降,包括基质细胞衍生因子-1α、生长分化因子-15、生长激素、血管内皮生长因子、血管生成素1和肝细胞生长因子。
  • 代谢和全身分解状态标志物发生变化,表现为生长分化因子-15、生长激素、三叶因子3和抵抗素下降,瘦素水平升高。

临床怎么用

  • 提示长期左心室辅助装置支持可能通过减轻炎症和有害心脏重构发挥心脏卸载后的生物学获益。

局限性

  • 本研究为探索性单中心观察性设计,样本量仅为16例。
  • 心肌组织学分析仅来自7例后续接受心脏移植的亚组患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background This study aimed to explore the association of long-term left ventricular assist device (LVAD) support with changes in inflammation and cardiac remodelling in subjects with advanced heart failure (HF). Methods A single-centre prospective observational trial was conducted in 16 consecutive subjects with advanced HF who were indicated for implantation of HeartMate 3 LVAD. Blood samples were collected both during the procedure (V1) and 12 months postoperatively (V2) for comprehensive analysis. Additionally, in a subgroup of seven LVAD subjects listed for heart transplantation (HTx), a histological examination was performed on myocardial samples obtained during LVAD implantation and from the explanted heart following HTx. Results LVAD implantation was associated with reductions in brain natriuretic peptide (324.7±47.0 vs 124.6±50.3 pg/mL) and C reactive protein (15.2±3.8 vs 6.0±1.3 mg/L) levels. Decreased inflammation markers coincided with reduced levels of lymphocyte- and macrophage-derived cytokines and their stimulating factors. LVAD implantation was associated with modulation of circulating biomarkers related to negative cardiac remodelling processes, including reductions in fibrosis- and remodelling-associated mediators (Extracellular Matrix Metalloproteinase Inducer, fibroblast growth factor (FGF)-2, FGF-19, receptor for advanced glycation endproducts, suppression of tumourigenicity 2, interleukin 27) and angiogenesis-related factors (stromal cell-derived factor-1α, growth differentiation factor (GDF)-15, somatotropin, vascular endothelial growth factor, angiopoietin 1, hepatocyte growth factor). In parallel, markers of metabolism and systemic catabolic state were significantly modulated, with decreases in GDF-15, somatotropin, trefoil factor 3 and resistin and increases in leptin levels. Histological analysis of myocardial samples available from a subgroup of subjects showed reduced macrophage infiltration following LVAD implantation. Conclusions Long-term LVAD support was associated with improved biochemical and haematological profiles and with coordinated changes in circulating markers of inflammation, metabolism and cardiac remodelling. These exploratory findings provide further insight into the biological changes associated with durable mechanical unloading in subjects with advanced HF.

来源:Open Heart,查看原文。版权归原作者所有。

引用

  1. Open Heart:Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。